GAMT p.Ala75=
c.225G>A · rs202151546 · VCV137433
ClinGen expert panel — Cerebral Creatine Deficiency Syndromes VCEP
Likely Benign for guanidinoacetate methyltransferase deficiency. Applied ACMG criteria (verbatim):
BS1 BP4
Curation rationale (ClinGen, verbatim)
The NM_000156.6(GAMT):c.225G>A (p.Ala75=) variant is a synonymous variant for which splicing prediction algorithms (SpliceAI, varSEAK) predict no impact to the splice consensus sequence nor the creation of a new splice site (BP4); however, the residue altered (Ala75) is conserved through zebrafish. Thus, BP7 is not met. The highest population minor allele frequency in gnomAD v2.1.1 is 0.00117 (21/17954 alleles) in the East Asian population, which is higher than the ClinGen CCDS VCEP’s threshold for BS1 (>0.001), and therefore meets this criterion (BS1). There is a ClinVar entry for this variant (Variation ID: 137433). In summary, this variant meets the crietria to be classified as likely benign for GAMT deficiency. GAMT-specific criteria applied, as specified by the ClinGen Cerebral Creatine Deficiency Syndromes Variant Curation Expert Panel (CCDS VCEP): BS1, BP4. (Classification approved by the ClinGen CCDS VCEP on March 9, 2023).
ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP 0.88 | GERP -3.1, phastCons 0.99 |
| Overall | ||
| CADD | 5.803 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 0.317% | 315 |
| South Asian | 0.00667% | 14,999 |
| European (non-Finnish) | 0.00365% | 27,403 |
| Admixed American | 0.00336% | 29,755 |
| Remaining individualsnot grpmax-eligible | 0.00161% | 62,288 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- GAMT
- Protein
- p.Ala75=
- Coding
- c.225G>A
- MANE Select
- NM_000156
- dbSNP
- rs202151546
- Type
- single nucleotide variant
- Location
- chr19:1399895 (GRCh38)
- Gene constraint
- LOEUF 1.536 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 96.73 · 1 PDB
- Residue 75
- the rmt2 domain; a UniProt-annotated variant site (in ccds2; retains no significant activity); an α-helix
Disease context
guanidinoacetate methyltransferase deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: cerebral creatine deficiency syndrome
For Guanidinoacetate methyltransferase deficiency (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Childhood, Infancy
Similar variants
- GAMT p.Ala75Val Pathogenic ★★★ same residue
- GAMT p.Ala75Glu Conflicting classifications of pathogenicity ★ ⚠ same residue
- GAMT p.Ala75Thr Uncertain significance ★ ⚠ same residue
- GAMT c.327+43G>A Likely pathogenic ★★★ same condition
- GAMT c.328-1G>A Pathogenic ★★★ same condition
- GAMT c.328-2A>G Pathogenic ★★★ same condition
- GAMT c.391+15G>T Likely pathogenic ★★★ same condition
- GAMT c.391+1G>C Pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/gamt-p-ala75 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown